nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—hepatitis B—acquired immunodeficiency syndrome	0.238	1	CtDrD
Lamivudine—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.137	1	CrCrCtD
Lamivudine—Nucleoside Reverse Transcriptase Inhibitors—Abacavir—acquired immunodeficiency syndrome	0.0688	0.172	CiPCiCtD
Lamivudine—Nucleoside Reverse Transcriptase Inhibitors—Stavudine—acquired immunodeficiency syndrome	0.0688	0.172	CiPCiCtD
Lamivudine—Nucleoside Reverse Transcriptase Inhibitors—Zidovudine—acquired immunodeficiency syndrome	0.0688	0.172	CiPCiCtD
Lamivudine—Nucleoside Reverse Transcriptase Inhibitors—Didanosine—acquired immunodeficiency syndrome	0.0688	0.172	CiPCiCtD
Lamivudine—Nucleoside Analog—Zidovudine—acquired immunodeficiency syndrome	0.0309	0.0776	CiPCiCtD
Lamivudine—Nucleoside Analog—Didanosine—acquired immunodeficiency syndrome	0.0309	0.0776	CiPCiCtD
Lamivudine—Nucleoside Analog—Abacavir—acquired immunodeficiency syndrome	0.0309	0.0776	CiPCiCtD
Lamivudine—Nucleoside Analog—Stavudine—acquired immunodeficiency syndrome	0.0309	0.0776	CiPCiCtD
Lamivudine—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.00993	0.07	CbGbCtD
Lamivudine—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.00982	0.0692	CbGbCtD
Lamivudine—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.00898	0.0633	CbGbCtD
Lamivudine—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.00858	0.0604	CbGbCtD
Lamivudine—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.00753	0.053	CbGbCtD
Lamivudine—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.00753	0.053	CbGbCtD
Lamivudine—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.00744	0.0524	CbGbCtD
Lamivudine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.00675	0.0476	CbGbCtD
Lamivudine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.00656	0.0462	CbGbCtD
Lamivudine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.00654	0.0461	CbGbCtD
Lamivudine—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.00635	0.0447	CbGbCtD
Lamivudine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.00593	0.0418	CbGbCtD
Lamivudine—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.00557	0.0393	CbGbCtD
Lamivudine—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.00557	0.0393	CbGbCtD
Lamivudine—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.00557	0.0392	CbGbCtD
Lamivudine—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.00504	0.0355	CbGbCtD
Lamivudine—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.00504	0.0355	CbGbCtD
Lamivudine—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.00483	0.034	CbGbCtD
Lamivudine—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.00391	0.0275	CbGbCtD
Lamivudine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00265	0.0187	CbGbCtD
Lamivudine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0024	0.0169	CbGbCtD
Lamivudine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00207	0.0146	CbGbCtD
Lamivudine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00201	0.0141	CbGbCtD
Lamivudine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00182	0.0128	CbGbCtD
Lamivudine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00182	0.0128	CbGbCtD
Lamivudine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00174	0.0123	CbGbCtD
Lamivudine—PCYT2—Glycerophospholipid Biosynthetic Pathway—AGPS—acquired immunodeficiency syndrome	0.000593	0.41	CbGpPWpGaD
Lamivudine—NME2—blood plasma—acquired immunodeficiency syndrome	0.000542	0.0294	CbGeAlD
Lamivudine—PGK1—skin of body—acquired immunodeficiency syndrome	0.000522	0.0283	CbGeAlD
Lamivudine—PCYT2—digestive system—acquired immunodeficiency syndrome	0.000486	0.0263	CbGeAlD
Lamivudine—PGK1—digestive system—acquired immunodeficiency syndrome	0.000418	0.0226	CbGeAlD
Lamivudine—PGK1—blood—acquired immunodeficiency syndrome	0.000398	0.0215	CbGeAlD
Lamivudine—PCYT2—nervous system—acquired immunodeficiency syndrome	0.000376	0.0204	CbGeAlD
Lamivudine—PCYT2—central nervous system—acquired immunodeficiency syndrome	0.000362	0.0196	CbGeAlD
Lamivudine—NT5C—lymphoid tissue—acquired immunodeficiency syndrome	0.000357	0.0193	CbGeAlD
Lamivudine—NT5C—blood—acquired immunodeficiency syndrome	0.000336	0.0182	CbGeAlD
Lamivudine—PCYT1A—digestive system—acquired immunodeficiency syndrome	0.000331	0.0179	CbGeAlD
Lamivudine—PGK1—nervous system—acquired immunodeficiency syndrome	0.000323	0.0175	CbGeAlD
Lamivudine—NME1—Indinavir—Nelfinavir—acquired immunodeficiency syndrome	0.000316	0.389	CbGdCrCtD
Lamivudine—NT5C—vagina—acquired immunodeficiency syndrome	0.000311	0.0169	CbGeAlD
Lamivudine—PGK1—central nervous system—acquired immunodeficiency syndrome	0.000311	0.0168	CbGeAlD
Lamivudine—NME2—retina—acquired immunodeficiency syndrome	0.000297	0.0161	CbGeAlD
Lamivudine—NT5C—lung—acquired immunodeficiency syndrome	0.000295	0.016	CbGeAlD
Lamivudine—PCYT2—brain—acquired immunodeficiency syndrome	0.000287	0.0156	CbGeAlD
Lamivudine—NME1—skin of body—acquired immunodeficiency syndrome	0.000277	0.015	CbGeAlD
Lamivudine—PCYT1A—lung—acquired immunodeficiency syndrome	0.000276	0.015	CbGeAlD
Lamivudine—NT5C—nervous system—acquired immunodeficiency syndrome	0.000273	0.0148	CbGeAlD
Lamivudine—CMPK1—skin of body—acquired immunodeficiency syndrome	0.000267	0.0144	CbGeAlD
Lamivudine—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.000264	0.0143	CbGeAlD
Lamivudine—NT5C—central nervous system—acquired immunodeficiency syndrome	0.000263	0.0142	CbGeAlD
Lamivudine—NME1—Indinavir—Lopinavir—acquired immunodeficiency syndrome	0.000258	0.317	CbGdCrCtD
Lamivudine—PCYT1A—nervous system—acquired immunodeficiency syndrome	0.000256	0.0139	CbGeAlD
Lamivudine—PGK1—brain—acquired immunodeficiency syndrome	0.000247	0.0134	CbGeAlD
Lamivudine—PCYT1A—central nervous system—acquired immunodeficiency syndrome	0.000246	0.0133	CbGeAlD
Lamivudine—NME1—Indinavir—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.295	CbGdCrCtD
Lamivudine—NME1—lymphoid tissue—acquired immunodeficiency syndrome	0.000224	0.0121	CbGeAlD
Lamivudine—NME1—digestive system—acquired immunodeficiency syndrome	0.000221	0.012	CbGeAlD
Lamivudine—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.000218	0.0118	CbGeAlD
Lamivudine—NME1-NME2—lymph node—acquired immunodeficiency syndrome	0.000217	0.0118	CbGeAlD
Lamivudine—CMPK1—lymphoid tissue—acquired immunodeficiency syndrome	0.000216	0.0117	CbGeAlD
Lamivudine—CMPK1—digestive system—acquired immunodeficiency syndrome	0.000213	0.0115	CbGeAlD
Lamivudine—NME2—lymphoid tissue—acquired immunodeficiency syndrome	0.000211	0.0114	CbGeAlD
Lamivudine—NT5C—brain—acquired immunodeficiency syndrome	0.000208	0.0113	CbGeAlD
Lamivudine—NME2—digestive system—acquired immunodeficiency syndrome	0.000208	0.0113	CbGeAlD
Lamivudine—NME1—bone marrow—acquired immunodeficiency syndrome	0.000204	0.011	CbGeAlD
Lamivudine—CMPK1—blood—acquired immunodeficiency syndrome	0.000203	0.011	CbGeAlD
Lamivudine—NT5C—lymph node—acquired immunodeficiency syndrome	0.000201	0.0109	CbGeAlD
Lamivudine—NME2—blood—acquired immunodeficiency syndrome	0.000199	0.0108	CbGeAlD
Lamivudine—CMPK1—bone marrow—acquired immunodeficiency syndrome	0.000197	0.0106	CbGeAlD
Lamivudine—CMPK1—spinal cord—acquired immunodeficiency syndrome	0.000196	0.0106	CbGeAlD
Lamivudine—PCYT1A—brain—acquired immunodeficiency syndrome	0.000196	0.0106	CbGeAlD
Lamivudine—CMPK1—vagina—acquired immunodeficiency syndrome	0.000188	0.0102	CbGeAlD
Lamivudine—NME1—lung—acquired immunodeficiency syndrome	0.000185	0.01	CbGeAlD
Lamivudine—CMPK1—lung—acquired immunodeficiency syndrome	0.000178	0.00965	CbGeAlD
Lamivudine—NME2—lung—acquired immunodeficiency syndrome	0.000174	0.00943	CbGeAlD
Lamivudine—NME1—nervous system—acquired immunodeficiency syndrome	0.000171	0.00927	CbGeAlD
Lamivudine—CMPK1—nervous system—acquired immunodeficiency syndrome	0.000165	0.00893	CbGeAlD
Lamivudine—NME1—central nervous system—acquired immunodeficiency syndrome	0.000165	0.00892	CbGeAlD
Lamivudine—NME2—nervous system—acquired immunodeficiency syndrome	0.000161	0.00873	CbGeAlD
Lamivudine—CMPK1—central nervous system—acquired immunodeficiency syndrome	0.000159	0.0086	CbGeAlD
Lamivudine—NME2—central nervous system—acquired immunodeficiency syndrome	0.000155	0.0084	CbGeAlD
Lamivudine—DCK—retina—acquired immunodeficiency syndrome	0.000151	0.00819	CbGeAlD
Lamivudine—NME1—brain—acquired immunodeficiency syndrome	0.000131	0.00708	CbGeAlD
Lamivudine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000128	0.00694	CbGeAlD
Lamivudine—NME1—lymph node—acquired immunodeficiency syndrome	0.000126	0.00684	CbGeAlD
Lamivudine—CMPK1—brain—acquired immunodeficiency syndrome	0.000126	0.00683	CbGeAlD
Lamivudine—NME2—brain—acquired immunodeficiency syndrome	0.000123	0.00667	CbGeAlD
Lamivudine—CMPK1—lymph node—acquired immunodeficiency syndrome	0.000122	0.0066	CbGeAlD
Lamivudine—NME2—lymph node—acquired immunodeficiency syndrome	0.000119	0.00645	CbGeAlD
Lamivudine—DCK—lymphoid tissue—acquired immunodeficiency syndrome	0.000107	0.00582	CbGeAlD
Lamivudine—DCK—digestive system—acquired immunodeficiency syndrome	0.000106	0.00575	CbGeAlD
Lamivudine—ABCC3—digestive system—acquired immunodeficiency syndrome	0.000102	0.00551	CbGeAlD
Lamivudine—DCK—blood—acquired immunodeficiency syndrome	0.000101	0.00548	CbGeAlD
Lamivudine—DCK—bone marrow—acquired immunodeficiency syndrome	9.79e-05	0.0053	CbGeAlD
Lamivudine—DCK—spinal cord—acquired immunodeficiency syndrome	9.75e-05	0.00528	CbGeAlD
Lamivudine—ABCC3—blood—acquired immunodeficiency syndrome	9.68e-05	0.00525	CbGeAlD
Lamivudine—DCK—vagina—acquired immunodeficiency syndrome	9.38e-05	0.00508	CbGeAlD
Lamivudine—DCK—lung—acquired immunodeficiency syndrome	8.87e-05	0.0048	CbGeAlD
Lamivudine—SLC22A1—blood—acquired immunodeficiency syndrome	8.63e-05	0.00467	CbGeAlD
Lamivudine—ABCC3—lung—acquired immunodeficiency syndrome	8.49e-05	0.0046	CbGeAlD
Lamivudine—ABCC4—digestive system—acquired immunodeficiency syndrome	8.39e-05	0.00454	CbGeAlD
Lamivudine—SLC22A6—brain—acquired immunodeficiency syndrome	8.22e-05	0.00445	CbGeAlD
Lamivudine—DCK—nervous system—acquired immunodeficiency syndrome	8.21e-05	0.00445	CbGeAlD
Lamivudine—ABCC2—digestive system—acquired immunodeficiency syndrome	8.12e-05	0.0044	CbGeAlD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	8.12e-05	0.0561	CbGpPWpGaD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	8.12e-05	0.0561	CbGpPWpGaD
Lamivudine—SLC22A1—vagina—acquired immunodeficiency syndrome	8e-05	0.00433	CbGeAlD
Lamivudine—ABCC4—blood—acquired immunodeficiency syndrome	7.99e-05	0.00433	CbGeAlD
Lamivudine—DCK—central nervous system—acquired immunodeficiency syndrome	7.91e-05	0.00428	CbGeAlD
Lamivudine—ABCC3—nervous system—acquired immunodeficiency syndrome	7.86e-05	0.00426	CbGeAlD
Lamivudine—ABCC2—blood—acquired immunodeficiency syndrome	7.74e-05	0.00419	CbGeAlD
Lamivudine—ABCC4—bone marrow—acquired immunodeficiency syndrome	7.74e-05	0.00419	CbGeAlD
Lamivudine—SLC22A3—vagina—acquired immunodeficiency syndrome	7.64e-05	0.00414	CbGeAlD
Lamivudine—ABCB1—blood plasma—acquired immunodeficiency syndrome	7.6e-05	0.00411	CbGeAlD
Lamivudine—ABCC3—central nervous system—acquired immunodeficiency syndrome	7.57e-05	0.0041	CbGeAlD
Lamivudine—SLC22A3—lung—acquired immunodeficiency syndrome	7.23e-05	0.00391	CbGeAlD
Lamivudine—ABCC4—lung—acquired immunodeficiency syndrome	7.01e-05	0.0038	CbGeAlD
Lamivudine—SLC22A1—nervous system—acquired immunodeficiency syndrome	7e-05	0.00379	CbGeAlD
Lamivudine—ABCC1—blood—acquired immunodeficiency syndrome	6.82e-05	0.00369	CbGeAlD
Lamivudine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	6.74e-05	0.00365	CbGeAlD
Lamivudine—SLC22A3—nervous system—acquired immunodeficiency syndrome	6.69e-05	0.00363	CbGeAlD
Lamivudine—ABCC4—nervous system—acquired immunodeficiency syndrome	6.49e-05	0.00351	CbGeAlD
Lamivudine—SLC22A3—central nervous system—acquired immunodeficiency syndrome	6.44e-05	0.00349	CbGeAlD
Lamivudine—ABCC1—vagina—acquired immunodeficiency syndrome	6.32e-05	0.00342	CbGeAlD
Lamivudine—DCK—brain—acquired immunodeficiency syndrome	6.28e-05	0.0034	CbGeAlD
Lamivudine—ABCC4—central nervous system—acquired immunodeficiency syndrome	6.25e-05	0.00338	CbGeAlD
Lamivudine—DCK—lymph node—acquired immunodeficiency syndrome	6.06e-05	0.00328	CbGeAlD
Lamivudine—ABCC3—brain—acquired immunodeficiency syndrome	6.01e-05	0.00325	CbGeAlD
Lamivudine—ABCC1—lung—acquired immunodeficiency syndrome	5.98e-05	0.00324	CbGeAlD
Lamivudine—ABCC3—lymph node—acquired immunodeficiency syndrome	5.81e-05	0.00314	CbGeAlD
Lamivudine—ABCG2—blood—acquired immunodeficiency syndrome	5.64e-05	0.00306	CbGeAlD
Lamivudine—ABCG2—bone marrow—acquired immunodeficiency syndrome	5.46e-05	0.00296	CbGeAlD
Lamivudine—ABCG2—spinal cord—acquired immunodeficiency syndrome	5.44e-05	0.00294	CbGeAlD
Lamivudine—SLC22A1—brain—acquired immunodeficiency syndrome	5.35e-05	0.0029	CbGeAlD
Lamivudine—ABCG2—vagina—acquired immunodeficiency syndrome	5.23e-05	0.00283	CbGeAlD
Lamivudine—SLC22A3—brain—acquired immunodeficiency syndrome	5.12e-05	0.00277	CbGeAlD
Lamivudine—ABCC4—brain—acquired immunodeficiency syndrome	4.96e-05	0.00269	CbGeAlD
Lamivudine—ABCG2—lung—acquired immunodeficiency syndrome	4.95e-05	0.00268	CbGeAlD
Lamivudine—SLC22A3—lymph node—acquired immunodeficiency syndrome	4.94e-05	0.00268	CbGeAlD
Lamivudine—ABCC4—lymph node—acquired immunodeficiency syndrome	4.79e-05	0.0026	CbGeAlD
Lamivudine—ABCC2—lymph node—acquired immunodeficiency syndrome	4.64e-05	0.00251	CbGeAlD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.23e-05	0.0293	CbGpPWpGaD
Lamivudine—ABCC1—brain—acquired immunodeficiency syndrome	4.23e-05	0.00229	CbGeAlD
Lamivudine—ABCB1—retina—acquired immunodeficiency syndrome	4.16e-05	0.00225	CbGeAlD
Lamivudine—ABCC1—lymph node—acquired immunodeficiency syndrome	4.09e-05	0.00221	CbGeAlD
Lamivudine—ABCG2—brain—acquired immunodeficiency syndrome	3.5e-05	0.0019	CbGeAlD
Lamivudine—ABCG2—lymph node—acquired immunodeficiency syndrome	3.38e-05	0.00183	CbGeAlD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.21e-05	0.0222	CbGpPWpGaD
Lamivudine—ABCC3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	3.16e-05	0.0219	CbGpPWpGaD
Lamivudine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	2.96e-05	0.0016	CbGeAlD
Lamivudine—ABCB1—digestive system—acquired immunodeficiency syndrome	2.92e-05	0.00158	CbGeAlD
Lamivudine—ABCB1—blood—acquired immunodeficiency syndrome	2.78e-05	0.00151	CbGeAlD
Lamivudine—ABCB1—bone marrow—acquired immunodeficiency syndrome	2.69e-05	0.00146	CbGeAlD
Lamivudine—ABCB1—spinal cord—acquired immunodeficiency syndrome	2.68e-05	0.00145	CbGeAlD
Lamivudine—ABCB1—vagina—acquired immunodeficiency syndrome	2.58e-05	0.0014	CbGeAlD
Lamivudine—ABCB1—lung—acquired immunodeficiency syndrome	2.44e-05	0.00132	CbGeAlD
Lamivudine—ABCB1—nervous system—acquired immunodeficiency syndrome	2.26e-05	0.00122	CbGeAlD
Lamivudine—NT5C—Metabolism—TAT—acquired immunodeficiency syndrome	2.22e-05	0.0153	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—TAT—acquired immunodeficiency syndrome	2.22e-05	0.0153	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—TAT—acquired immunodeficiency syndrome	2.22e-05	0.0153	CbGpPWpGaD
Lamivudine—ABCB1—central nervous system—acquired immunodeficiency syndrome	2.17e-05	0.00118	CbGeAlD
Lamivudine—PCYT2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.89e-05	0.013	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.89e-05	0.013	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AGPS—acquired immunodeficiency syndrome	1.89e-05	0.013	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—TAT—acquired immunodeficiency syndrome	1.81e-05	0.0125	CbGpPWpGaD
Lamivudine—ABCB1—brain—acquired immunodeficiency syndrome	1.73e-05	0.000935	CbGeAlD
Lamivudine—PGK1—Disease—APOBEC3G—acquired immunodeficiency syndrome	1.73e-05	0.0119	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—TAT—acquired immunodeficiency syndrome	1.68e-05	0.0116	CbGpPWpGaD
Lamivudine—ABCB1—lymph node—acquired immunodeficiency syndrome	1.67e-05	0.000904	CbGeAlD
Lamivudine—ABCC3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	1.65e-05	0.0114	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.54e-05	0.0106	CbGpPWpGaD
Lamivudine—NME2—Metabolism—TAT—acquired immunodeficiency syndrome	1.54e-05	0.0106	CbGpPWpGaD
Lamivudine—PGK1—Disease—CCNT1—acquired immunodeficiency syndrome	1.47e-05	0.0101	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	1.44e-05	0.00993	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	1.44e-05	0.00993	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AGPS—acquired immunodeficiency syndrome	1.43e-05	0.00988	CbGpPWpGaD
Lamivudine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	1.36e-05	0.000212	CcSEcCtD
Lamivudine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	1.35e-05	0.000212	CcSEcCtD
Lamivudine—Pain—Zidovudine—acquired immunodeficiency syndrome	1.35e-05	0.000211	CcSEcCtD
Lamivudine—Constipation—Zidovudine—acquired immunodeficiency syndrome	1.35e-05	0.000211	CcSEcCtD
Lamivudine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	1.35e-05	0.000211	CcSEcCtD
Lamivudine—Syncope—Ritonavir—acquired immunodeficiency syndrome	1.35e-05	0.000211	CcSEcCtD
Lamivudine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	1.35e-05	0.000211	CcSEcCtD
Lamivudine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	1.35e-05	0.000211	CcSEcCtD
Lamivudine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	1.34e-05	0.00021	CcSEcCtD
Lamivudine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	1.34e-05	0.00021	CcSEcCtD
Lamivudine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	1.34e-05	0.00021	CcSEcCtD
Lamivudine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	1.34e-05	0.00021	CcSEcCtD
Lamivudine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	1.34e-05	0.00021	CcSEcCtD
Lamivudine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	1.34e-05	0.00021	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	1.34e-05	0.00021	CcSEcCtD
Lamivudine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	1.33e-05	0.000208	CcSEcCtD
Lamivudine—Vomiting—Didanosine—acquired immunodeficiency syndrome	1.33e-05	0.000208	CcSEcCtD
Lamivudine—Insomnia—Indinavir—acquired immunodeficiency syndrome	1.33e-05	0.000208	CcSEcCtD
Lamivudine—Oedema—Delavirdine—acquired immunodeficiency syndrome	1.33e-05	0.000208	CcSEcCtD
Lamivudine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	1.32e-05	0.000207	CcSEcCtD
Lamivudine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	1.32e-05	0.000207	CcSEcCtD
Lamivudine—Rash—Didanosine—acquired immunodeficiency syndrome	1.32e-05	0.000207	CcSEcCtD
Lamivudine—Infection—Delavirdine—acquired immunodeficiency syndrome	1.32e-05	0.000207	CcSEcCtD
Lamivudine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	1.32e-05	0.000207	CcSEcCtD
Lamivudine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	1.32e-05	0.000206	CcSEcCtD
Lamivudine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	1.32e-05	0.000206	CcSEcCtD
Lamivudine—Cough—Ritonavir—acquired immunodeficiency syndrome	1.31e-05	0.000206	CcSEcCtD
Lamivudine—Headache—Didanosine—acquired immunodeficiency syndrome	1.31e-05	0.000205	CcSEcCtD
Lamivudine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	1.31e-05	0.000205	CcSEcCtD
Lamivudine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	1.31e-05	0.000205	CcSEcCtD
Lamivudine—Shock—Delavirdine—acquired immunodeficiency syndrome	1.31e-05	0.000205	CcSEcCtD
Lamivudine—NME2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.31e-05	0.00903	CbGpPWpGaD
Lamivudine—Malaise—Saquinavir—acquired immunodeficiency syndrome	1.31e-05	0.000204	CcSEcCtD
Lamivudine—Somnolence—Indinavir—acquired immunodeficiency syndrome	1.31e-05	0.000204	CcSEcCtD
Lamivudine—Asthenia—Stavudine—acquired immunodeficiency syndrome	1.3e-05	0.000204	CcSEcCtD
Lamivudine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	1.3e-05	0.000204	CcSEcCtD
Lamivudine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	1.3e-05	0.000204	CcSEcCtD
Lamivudine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	1.3e-05	0.000204	CcSEcCtD
Lamivudine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	1.3e-05	0.000204	CcSEcCtD
Lamivudine—Syncope—Saquinavir—acquired immunodeficiency syndrome	1.3e-05	0.000203	CcSEcCtD
Lamivudine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	1.3e-05	0.000203	CcSEcCtD
Lamivudine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	1.29e-05	0.000202	CcSEcCtD
Lamivudine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	1.29e-05	0.000202	CcSEcCtD
Lamivudine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	1.29e-05	0.000202	CcSEcCtD
Lamivudine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	1.29e-05	0.000202	CcSEcCtD
Lamivudine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	1.29e-05	0.000202	CcSEcCtD
Lamivudine—Pruritus—Stavudine—acquired immunodeficiency syndrome	1.29e-05	0.000201	CcSEcCtD
Lamivudine—Asthenia—Abacavir—acquired immunodeficiency syndrome	1.29e-05	0.000201	CcSEcCtD
Lamivudine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	1.28e-05	0.000201	CcSEcCtD
Lamivudine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	1.28e-05	0.000201	CcSEcCtD
Lamivudine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	1.28e-05	0.000201	CcSEcCtD
Lamivudine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	1.28e-05	0.000201	CcSEcCtD
Lamivudine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	1.28e-05	0.0002	CcSEcCtD
Lamivudine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	1.28e-05	0.0002	CcSEcCtD
Lamivudine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	1.27e-05	0.000199	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	1.27e-05	0.000199	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	1.27e-05	0.000199	CcSEcCtD
Lamivudine—Pruritus—Abacavir—acquired immunodeficiency syndrome	1.27e-05	0.000198	CcSEcCtD
Lamivudine—Fatigue—Indinavir—acquired immunodeficiency syndrome	1.27e-05	0.000198	CcSEcCtD
Lamivudine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	1.27e-05	0.000198	CcSEcCtD
Lamivudine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	1.27e-05	0.000198	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	1.27e-05	0.000198	CcSEcCtD
Lamivudine—Cough—Saquinavir—acquired immunodeficiency syndrome	1.26e-05	0.000198	CcSEcCtD
Lamivudine—Pain—Indinavir—acquired immunodeficiency syndrome	1.26e-05	0.000197	CcSEcCtD
Lamivudine—Constipation—Indinavir—acquired immunodeficiency syndrome	1.26e-05	0.000197	CcSEcCtD
Lamivudine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	1.26e-05	0.000197	CcSEcCtD
Lamivudine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	1.26e-05	0.000196	CcSEcCtD
Lamivudine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	1.26e-05	0.000196	CcSEcCtD
Lamivudine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	1.25e-05	0.000196	CcSEcCtD
Lamivudine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	1.25e-05	0.000195	CcSEcCtD
Lamivudine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	1.25e-05	0.000195	CcSEcCtD
Lamivudine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	1.25e-05	0.000195	CcSEcCtD
Lamivudine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	1.25e-05	0.000195	CcSEcCtD
Lamivudine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	1.24e-05	0.000195	CcSEcCtD
Lamivudine—Nausea—Didanosine—acquired immunodeficiency syndrome	1.24e-05	0.000195	CcSEcCtD
Lamivudine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	1.24e-05	0.000194	CcSEcCtD
Lamivudine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	1.24e-05	0.000194	CcSEcCtD
Lamivudine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	1.24e-05	0.000194	CcSEcCtD
Lamivudine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	1.23e-05	0.000193	CcSEcCtD
Lamivudine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	1.23e-05	0.000193	CcSEcCtD
Lamivudine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	1.23e-05	0.000193	CcSEcCtD
Lamivudine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	1.23e-05	0.000193	CcSEcCtD
Lamivudine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	1.23e-05	0.000192	CcSEcCtD
Lamivudine—Oedema—Ritonavir—acquired immunodeficiency syndrome	1.23e-05	0.000192	CcSEcCtD
Lamivudine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	1.23e-05	0.000192	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	1.23e-05	0.000192	CcSEcCtD
Lamivudine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	1.22e-05	0.000191	CcSEcCtD
Lamivudine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	1.22e-05	0.000191	CcSEcCtD
Lamivudine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	1.21e-05	0.00019	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	1.21e-05	0.000189	CcSEcCtD
Lamivudine—Shock—Ritonavir—acquired immunodeficiency syndrome	1.21e-05	0.000189	CcSEcCtD
Lamivudine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	1.21e-05	0.000189	CcSEcCtD
Lamivudine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	1.21e-05	0.000189	CcSEcCtD
Lamivudine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	1.21e-05	0.000189	CcSEcCtD
Lamivudine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	1.21e-05	0.000189	CcSEcCtD
Lamivudine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	1.2e-05	0.000188	CcSEcCtD
Lamivudine—Dizziness—Stavudine—acquired immunodeficiency syndrome	1.2e-05	0.000188	CcSEcCtD
Lamivudine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	1.2e-05	0.000188	CcSEcCtD
Lamivudine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	1.2e-05	0.000188	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	1.2e-05	0.000188	CcSEcCtD
Lamivudine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	1.2e-05	0.000187	CcSEcCtD
Lamivudine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	1.2e-05	0.000187	CcSEcCtD
Lamivudine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	1.19e-05	0.000187	CcSEcCtD
Lamivudine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	1.19e-05	0.000187	CcSEcCtD
Lamivudine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	1.19e-05	0.000187	CcSEcCtD
Lamivudine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	1.19e-05	0.000186	CcSEcCtD
Lamivudine—Pain—Efavirenz—acquired immunodeficiency syndrome	1.19e-05	0.000186	CcSEcCtD
Lamivudine—Constipation—Efavirenz—acquired immunodeficiency syndrome	1.19e-05	0.000186	CcSEcCtD
Lamivudine—Rash—Nevirapine—acquired immunodeficiency syndrome	1.19e-05	0.000186	CcSEcCtD
Lamivudine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	1.19e-05	0.000186	CcSEcCtD
Lamivudine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	1.18e-05	0.000185	CcSEcCtD
Lamivudine—Dizziness—Abacavir—acquired immunodeficiency syndrome	1.18e-05	0.000185	CcSEcCtD
Lamivudine—Oedema—Saquinavir—acquired immunodeficiency syndrome	1.18e-05	0.000185	CcSEcCtD
Lamivudine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	1.18e-05	0.000185	CcSEcCtD
Lamivudine—Headache—Nevirapine—acquired immunodeficiency syndrome	1.18e-05	0.000185	CcSEcCtD
Lamivudine—Infection—Saquinavir—acquired immunodeficiency syndrome	1.17e-05	0.000184	CcSEcCtD
Lamivudine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	1.17e-05	0.000183	CcSEcCtD
Lamivudine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	1.17e-05	0.000183	CcSEcCtD
Lamivudine—Urticaria—Indinavir—acquired immunodeficiency syndrome	1.17e-05	0.000183	CcSEcCtD
Lamivudine—NME1—Metabolism—TAT—acquired immunodeficiency syndrome	1.16e-05	0.00805	CbGpPWpGaD
Lamivudine—Shock—Saquinavir—acquired immunodeficiency syndrome	1.16e-05	0.000182	CcSEcCtD
Lamivudine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	1.16e-05	0.000182	CcSEcCtD
Lamivudine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	1.16e-05	0.000182	CcSEcCtD
Lamivudine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	1.16e-05	0.000181	CcSEcCtD
Lamivudine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	1.16e-05	0.000181	CcSEcCtD
Lamivudine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	1.16e-05	0.000181	CcSEcCtD
Lamivudine—Vomiting—Stavudine—acquired immunodeficiency syndrome	1.16e-05	0.000181	CcSEcCtD
Lamivudine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	1.16e-05	0.000181	CcSEcCtD
Lamivudine—Rash—Nelfinavir—acquired immunodeficiency syndrome	1.15e-05	0.00018	CcSEcCtD
Lamivudine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	1.15e-05	0.00018	CcSEcCtD
Lamivudine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	1.15e-05	0.00018	CcSEcCtD
Lamivudine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	1.15e-05	0.00018	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	1.15e-05	0.000179	CcSEcCtD
Lamivudine—Rash—Stavudine—acquired immunodeficiency syndrome	1.15e-05	0.000179	CcSEcCtD
Lamivudine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	1.15e-05	0.000179	CcSEcCtD
Lamivudine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	1.15e-05	0.000179	CcSEcCtD
Lamivudine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	1.14e-05	0.000179	CcSEcCtD
Lamivudine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	1.14e-05	0.000179	CcSEcCtD
Lamivudine—Headache—Nelfinavir—acquired immunodeficiency syndrome	1.14e-05	0.000179	CcSEcCtD
Lamivudine—Headache—Stavudine—acquired immunodeficiency syndrome	1.14e-05	0.000178	CcSEcCtD
Lamivudine—Vomiting—Abacavir—acquired immunodeficiency syndrome	1.14e-05	0.000178	CcSEcCtD
Lamivudine—Constipation—Delavirdine—acquired immunodeficiency syndrome	1.14e-05	0.000178	CcSEcCtD
Lamivudine—Pain—Delavirdine—acquired immunodeficiency syndrome	1.14e-05	0.000178	CcSEcCtD
Lamivudine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	1.14e-05	0.000178	CcSEcCtD
Lamivudine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	1.13e-05	0.000177	CcSEcCtD
Lamivudine—Rash—Abacavir—acquired immunodeficiency syndrome	1.13e-05	0.000177	CcSEcCtD
Lamivudine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	1.13e-05	0.000177	CcSEcCtD
Lamivudine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	1.13e-05	0.000176	CcSEcCtD
Lamivudine—Headache—Abacavir—acquired immunodeficiency syndrome	1.12e-05	0.000176	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	1.12e-05	0.000175	CcSEcCtD
Lamivudine—Nausea—Nevirapine—acquired immunodeficiency syndrome	1.12e-05	0.000175	CcSEcCtD
Lamivudine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	1.12e-05	0.000175	CcSEcCtD
Lamivudine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	1.11e-05	0.000174	CcSEcCtD
Lamivudine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	1.11e-05	0.000173	CcSEcCtD
Lamivudine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	1.1e-05	0.000173	CcSEcCtD
Lamivudine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	1.1e-05	0.000173	CcSEcCtD
Lamivudine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	1.1e-05	0.000172	CcSEcCtD
Lamivudine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	1.1e-05	0.000172	CcSEcCtD
Lamivudine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	1.1e-05	0.000171	CcSEcCtD
Lamivudine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	1.09e-05	0.000171	CcSEcCtD
Lamivudine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	1.09e-05	0.000171	CcSEcCtD
Lamivudine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	1.09e-05	0.00017	CcSEcCtD
Lamivudine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	1.08e-05	0.00017	CcSEcCtD
Lamivudine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	1.08e-05	0.000169	CcSEcCtD
Lamivudine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	1.08e-05	0.000169	CcSEcCtD
Lamivudine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	1.08e-05	0.000169	CcSEcCtD
Lamivudine—Nausea—Stavudine—acquired immunodeficiency syndrome	1.08e-05	0.000169	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	1.08e-05	0.000169	CcSEcCtD
Lamivudine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	1.07e-05	0.000167	CcSEcCtD
Lamivudine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	1.07e-05	0.000167	CcSEcCtD
Lamivudine—Nausea—Abacavir—acquired immunodeficiency syndrome	1.06e-05	0.000166	CcSEcCtD
Lamivudine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	1.06e-05	0.000166	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	1.06e-05	0.000166	CcSEcCtD
Lamivudine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	1.06e-05	0.000166	CcSEcCtD
Lamivudine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	1.06e-05	0.000165	CcSEcCtD
Lamivudine—Asthenia—Indinavir—acquired immunodeficiency syndrome	1.05e-05	0.000165	CcSEcCtD
Lamivudine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	1.05e-05	0.000165	CcSEcCtD
Lamivudine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	1.05e-05	0.000165	CcSEcCtD
Lamivudine—Pain—Ritonavir—acquired immunodeficiency syndrome	1.05e-05	0.000164	CcSEcCtD
Lamivudine—Constipation—Ritonavir—acquired immunodeficiency syndrome	1.05e-05	0.000164	CcSEcCtD
Lamivudine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	1.05e-05	0.000164	CcSEcCtD
Lamivudine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	1.05e-05	0.000164	CcSEcCtD
Lamivudine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	1.05e-05	0.000164	CcSEcCtD
Lamivudine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	1.04e-05	0.000163	CcSEcCtD
Lamivudine—Pruritus—Indinavir—acquired immunodeficiency syndrome	1.04e-05	0.000163	CcSEcCtD
Lamivudine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	1.03e-05	0.000161	CcSEcCtD
Lamivudine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	1.02e-05	0.00016	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	1.02e-05	0.00016	CcSEcCtD
Lamivudine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	1.02e-05	0.00016	CcSEcCtD
Lamivudine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	1.01e-05	0.000158	CcSEcCtD
Lamivudine—Pain—Saquinavir—acquired immunodeficiency syndrome	1.01e-05	0.000158	CcSEcCtD
Lamivudine—Constipation—Saquinavir—acquired immunodeficiency syndrome	1.01e-05	0.000158	CcSEcCtD
Lamivudine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	1.01e-05	0.000157	CcSEcCtD
Lamivudine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	1e-05	0.000157	CcSEcCtD
Lamivudine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	1e-05	0.000157	CcSEcCtD
Lamivudine—Rash—Zidovudine—acquired immunodeficiency syndrome	9.97e-06	0.000156	CcSEcCtD
Lamivudine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.96e-06	0.000156	CcSEcCtD
Lamivudine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.96e-06	0.000156	CcSEcCtD
Lamivudine—NME1—Metabolism—AGPS—acquired immunodeficiency syndrome	9.9e-06	0.00685	CbGpPWpGaD
Lamivudine—Headache—Zidovudine—acquired immunodeficiency syndrome	9.9e-06	0.000155	CcSEcCtD
Lamivudine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.83e-06	0.000154	CcSEcCtD
Lamivudine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.79e-06	0.000153	CcSEcCtD
Lamivudine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.76e-06	0.000153	CcSEcCtD
Lamivudine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.75e-06	0.000152	CcSEcCtD
Lamivudine—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.72e-06	0.000152	CcSEcCtD
Lamivudine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.71e-06	0.000152	CcSEcCtD
Lamivudine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.71e-06	0.000152	CcSEcCtD
Lamivudine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.67e-06	0.000151	CcSEcCtD
Lamivudine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.53e-06	0.000149	CcSEcCtD
Lamivudine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.5e-06	0.000149	CcSEcCtD
Lamivudine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.4e-06	0.000147	CcSEcCtD
Lamivudine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.4e-06	0.000147	CcSEcCtD
Lamivudine—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.39e-06	0.000147	CcSEcCtD
Lamivudine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.35e-06	0.000146	CcSEcCtD
Lamivudine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.35e-06	0.000146	CcSEcCtD
Lamivudine—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.35e-06	0.000146	CcSEcCtD
Lamivudine—Rash—Indinavir—acquired immunodeficiency syndrome	9.27e-06	0.000145	CcSEcCtD
Lamivudine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.26e-06	0.000145	CcSEcCtD
Lamivudine—Headache—Indinavir—acquired immunodeficiency syndrome	9.21e-06	0.000144	CcSEcCtD
Lamivudine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.18e-06	0.000144	CcSEcCtD
Lamivudine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.09e-06	0.000142	CcSEcCtD
Lamivudine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	9.05e-06	0.000142	CcSEcCtD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.85e-06	0.00612	CbGpPWpGaD
Lamivudine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.83e-06	0.000138	CcSEcCtD
Lamivudine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.82e-06	0.000138	CcSEcCtD
Lamivudine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.79e-06	0.000137	CcSEcCtD
Lamivudine—Rash—Efavirenz—acquired immunodeficiency syndrome	8.76e-06	0.000137	CcSEcCtD
Lamivudine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.75e-06	0.000137	CcSEcCtD
Lamivudine—Nausea—Indinavir—acquired immunodeficiency syndrome	8.73e-06	0.000137	CcSEcCtD
Lamivudine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.71e-06	0.000136	CcSEcCtD
Lamivudine—Headache—Efavirenz—acquired immunodeficiency syndrome	8.7e-06	0.000136	CcSEcCtD
Lamivudine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.69e-06	0.000136	CcSEcCtD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.68e-06	0.006	CbGpPWpGaD
Lamivudine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.49e-06	0.000133	CcSEcCtD
Lamivudine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.45e-06	0.000132	CcSEcCtD
Lamivudine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.41e-06	0.000132	CcSEcCtD
Lamivudine—Rash—Delavirdine—acquired immunodeficiency syndrome	8.38e-06	0.000131	CcSEcCtD
Lamivudine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.37e-06	0.000131	CcSEcCtD
Lamivudine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.37e-06	0.000131	CcSEcCtD
Lamivudine—Headache—Delavirdine—acquired immunodeficiency syndrome	8.32e-06	0.00013	CcSEcCtD
Lamivudine—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.25e-06	0.000129	CcSEcCtD
Lamivudine—ABCC4—Platelet degranulation—ALB—acquired immunodeficiency syndrome	8.2e-06	0.00567	CbGpPWpGaD
Lamivudine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.13e-06	0.000127	CcSEcCtD
Lamivudine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.09e-06	0.000127	CcSEcCtD
Lamivudine—DCK—Metabolism—TAT—acquired immunodeficiency syndrome	7.99e-06	0.00552	CbGpPWpGaD
Lamivudine—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.89e-06	0.000123	CcSEcCtD
Lamivudine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.82e-06	0.000122	CcSEcCtD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	7.81e-06	0.0054	CbGpPWpGaD
Lamivudine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.81e-06	0.000122	CcSEcCtD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	7.77e-06	0.00537	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	7.77e-06	0.00537	CbGpPWpGaD
Lamivudine—Rash—Ritonavir—acquired immunodeficiency syndrome	7.75e-06	0.000121	CcSEcCtD
Lamivudine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.74e-06	0.000121	CcSEcCtD
Lamivudine—PGK1—Disease—CXCR4—acquired immunodeficiency syndrome	7.71e-06	0.00533	CbGpPWpGaD
Lamivudine—Headache—Ritonavir—acquired immunodeficiency syndrome	7.7e-06	0.00012	CcSEcCtD
Lamivudine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.52e-06	0.000118	CcSEcCtD
Lamivudine—Rash—Saquinavir—acquired immunodeficiency syndrome	7.46e-06	0.000117	CcSEcCtD
Lamivudine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.45e-06	0.000117	CcSEcCtD
Lamivudine—Headache—Saquinavir—acquired immunodeficiency syndrome	7.41e-06	0.000116	CcSEcCtD
Lamivudine—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.3e-06	0.000114	CcSEcCtD
Lamivudine—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.02e-06	0.00011	CcSEcCtD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.94e-06	0.0048	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AGPS—acquired immunodeficiency syndrome	6.79e-06	0.0047	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	6.73e-06	0.00465	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.58e-06	0.00455	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	6.45e-06	0.00446	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	5.58e-06	0.00386	CbGpPWpGaD
Lamivudine—PGK1—Disease—CCR5—acquired immunodeficiency syndrome	5.28e-06	0.00365	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	5.1e-06	0.00352	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	5.1e-06	0.00352	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TAT—acquired immunodeficiency syndrome	5.04e-06	0.00349	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	4.96e-06	0.00343	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	4.85e-06	0.00335	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TAT—acquired immunodeficiency syndrome	4.64e-06	0.00321	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AGPS—acquired immunodeficiency syndrome	4.29e-06	0.00297	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AGPS—acquired immunodeficiency syndrome	3.94e-06	0.00273	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ALB—acquired immunodeficiency syndrome	3.87e-06	0.00267	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ALB—acquired immunodeficiency syndrome	3.87e-06	0.00267	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ALB—acquired immunodeficiency syndrome	3.87e-06	0.00267	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.7e-06	0.00256	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IFNA1—acquired immunodeficiency syndrome	3.68e-06	0.00254	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	3.64e-06	0.00252	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TAT—acquired immunodeficiency syndrome	3.63e-06	0.00251	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOBEC3G—acquired immunodeficiency syndrome	3.47e-06	0.0024	CbGpPWpGaD
Lamivudine—PGK1—Disease—CD4—acquired immunodeficiency syndrome	3.32e-06	0.00229	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	3.2e-06	0.00221	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.16e-06	0.00219	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ALB—acquired immunodeficiency syndrome	3.15e-06	0.00218	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.09e-06	0.00214	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3e-06	0.00207	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.95e-06	0.00204	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.95e-06	0.00204	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CCNT1—acquired immunodeficiency syndrome	2.95e-06	0.00204	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ALB—acquired immunodeficiency syndrome	2.93e-06	0.00203	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.88e-06	0.00199	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.78e-06	0.00192	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.72e-06	0.00188	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.69e-06	0.00186	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ALB—acquired immunodeficiency syndrome	2.68e-06	0.00185	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	2.66e-06	0.00184	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.51e-06	0.00173	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.32e-06	0.0016	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	2.16e-06	0.00149	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ALB—acquired immunodeficiency syndrome	2.03e-06	0.0014	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	1.94e-06	0.00134	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.88e-06	0.0013	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ALB—acquired immunodeficiency syndrome	1.88e-06	0.0013	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.82e-06	0.00126	CbGpPWpGaD
Lamivudine—PGK1—Disease—IL6—acquired immunodeficiency syndrome	1.79e-06	0.00124	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	1.73e-06	0.0012	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.73e-06	0.00119	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.62e-06	0.00112	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CXCR4—acquired immunodeficiency syndrome	1.55e-06	0.00107	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—acquired immunodeficiency syndrome	1.52e-06	0.00105	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.47e-06	0.00102	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.42e-06	0.000984	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.41e-06	0.000977	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—acquired immunodeficiency syndrome	1.39e-06	0.000963	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.37e-06	0.000946	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.35e-06	0.000935	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.19e-06	0.000823	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.18e-06	0.000814	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.1e-06	0.000759	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CCR5—acquired immunodeficiency syndrome	1.06e-06	0.000734	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.57e-07	0.000662	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	8.8e-07	0.000608	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—acquired immunodeficiency syndrome	8.09e-07	0.000559	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—acquired immunodeficiency syndrome	6.67e-07	0.000461	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.44e-07	0.000445	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—acquired immunodeficiency syndrome	6.34e-07	0.000438	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	5.58e-07	0.000385	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.52e-07	0.000381	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.14e-07	0.000356	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—acquired immunodeficiency syndrome	3.61e-07	0.000249	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.01e-07	0.000208	CbGpPWpGaD
